'"`UNIQ--vote-00001284-QINU`"' Systemic oral ketotifen (available outside US) has historical use for asthma adjunct therapy via the same dual mechanism, but oral use produces sedation and weight gain — the topical ophthalmic application largely avoids both'"`UNIQ--ref-00001285-QINU`"'.
uses
String
'"`UNIQ--vote-00001286-QINU`"'
starting_dose
String
Ophthalmic 1 drop in each eye every 8-12 hours
preparations
String
0.025%, 0.035% ophthalmic solutions
fda_max
String
1 drop per eye q8-12h
pill_id
Text
routes
List of String, delimiter: ,
Topical ophthalmic
onset
String
Within minutes
duration
String
8-12 hours
halflife
String
Not meaningfully described for ophthalmic use'"`UNIQ--ref-00001287-QINU`"'
bioavailability
String
Topical with minimal systemic absorption'"`UNIQ--ref-00001288-QINU`"'
pregnancy
String
Generally considered safe (minimal systemic exposure).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup>
